CHF pathophysiology - Nursing Case Study

Pathophysiology

• Primary mechanism: Heart pumping inefficiency - Congestive heart failure (CHF) occurs when the heart cannot effectively pump blood to meet the body's needs, often due to weakened heart muscle or damage from conditions like coronary artery disease or hypertension.

• Secondary mechanism: Fluid buildup - As the heart struggles to pump efficiently, blood may back up, leading to congestion in the lungs and fluid retention in the body, causing symptoms like swelling (edema) in the legs and difficulty breathing.

• Key complication: Reduced oxygen delivery - The impaired circulation in CHF results in insufficient oxygen supply to organs and tissues, which can lead to fatigue, weakness, and organ dysfunction if not managed appropriately.

Patient Profile

Demographics:

65, male, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Lisinopril, Metformin, Aspirin

• Allergies: None

Current Presentation:

• Chief complaint: Mild shortness of breath during exertion

• Key symptoms: Fatigue, mild ankle swelling

• Vital signs: Blood pressure 130/85 mmHg, heart rate 78 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 96% on room air

Section 1

Initial Assessment Findings:

The nursing team conducts a thorough initial assessment of the patient, focusing on the current presentation of mild exertional dyspnea and peripheral edema. During the cardiovascular assessment, the nurse notes a regular heart rhythm with no abnormal heart sounds such as murmurs or gallops. The patient reports experiencing mild fatigue, which he describes as a new symptom over the past few weeks. Upon inspection, there is slight pitting edema observed in both ankles, rated as 1+ on the edema scale. Lung auscultation reveals clear breath sounds bilaterally with no adventitious sounds, indicating that pulmonary congestion is not yet significant.

The nurse evaluates the patient's functional status, noting that although activities of daily living are largely maintained, the patient experiences increased shortness of breath during tasks like climbing stairs or walking for extended periods. The patient's blood glucose levels are within target range, as indicated by recent home monitoring records, and he reports adherence to his medication regimen. Vital signs remain stable, with blood pressure at 130/85 mmHg and heart rate at 78 bpm, suggesting that the current antihypertensive therapy is effective in managing his hypertension.

Based on these findings, the nursing team identifies key nursing diagnoses such as activity intolerance related to impaired oxygen delivery and fluid volume excess related to compromised cardiac function. The team emphasizes patient education on recognizing early signs of fluid overload and the importance of lifestyle modifications, including dietary sodium restriction and daily weight monitoring, to prevent exacerbation of heart failure symptoms. This assessment sets the stage for further diagnostic evaluations to refine the management plan and optimize patient outcomes.

Section 2

New Diagnostic Results:

Following the initial assessment, the healthcare team orders a series of diagnostic tests to gain a deeper understanding of the patient's cardiac function and to rule out any underlying complications that might be contributing to the early-stage CHF symptoms. The results of the echocardiogram reveal a mildly reduced ejection fraction of 45%, indicating some degree of systolic dysfunction. This finding aligns with the patient's symptoms of mild exertional dyspnea and peripheral edema. Blood tests show slightly elevated BNP (B-type Natriuretic Peptide) levels at 150 pg/mL, which is consistent with early heart failure but not alarmingly high, suggesting that the condition is manageable at this stage.

Additionally, routine lab work indicates normal renal function with creatinine at 0.9 mg/dL and electrolytes within normal ranges, ruling out renal impairment as a contributing factor to fluid retention. A chest X-ray is conducted to assess for any pulmonary congestion, and it returns normal, confirming that pulmonary edema is not present at this time. Based on these results, the healthcare team confirms the diagnosis of early-stage heart failure with preserved renal function and no immediate signs of pulmonary complications.

These diagnostic findings lead to the development of a tailored care plan focused on slowing the progression of heart failure. The healthcare team discusses the importance of medication adherence, emphasizing the role of ACE inhibitors in improving cardiac output and preventing further cardiac remodeling. Additionally, they reinforce lifestyle changes such as reducing sodium intake and engaging in regular, mild physical activity to improve cardiovascular endurance. The patient is encouraged to maintain regular follow-up appointments for ongoing monitoring and adjustment of the treatment plan as needed, setting the stage for continued management of his condition.

Section 3

Response to Interventions

Following the development of the care plan, the patient begins adhering to the prescribed regimen of ACE inhibitors, specifically lisinopril, at a low starting dose. After two weeks, the patient returns for a follow-up appointment to assess the response to interventions. During this visit, the healthcare team notes that the patient reports feeling slightly more energetic, with a reduction in episodes of exertional dyspnea. The peripheral edema has also noticeably decreased, which the patient attributes to being more vigilant about reducing sodium intake. These subjective improvements are encouraging and suggest a positive initial response to the treatment plan.

During the physical examination, the nurse records vital signs as follows: blood pressure is stable at 130/80 mmHg, heart rate is regular at 72 beats per minute, and respiratory rate is 18 breaths per minute with no signs of distress. The patient’s weight has decreased by 2 pounds since the last visit, potentially indicating a reduction in fluid retention. An updated BNP level is drawn and shows a slight decrease to 140 pg/mL, reinforcing the notion that the heart failure management is effectively stabilizing the condition.

The healthcare team discusses these findings with the patient, emphasizing the importance of continuing the current regimen and adherence to lifestyle modifications. They also remind the patient about the significance of monitoring for any signs of worsening symptoms, such as increased shortness of breath or swelling, which would necessitate a prompt reevaluation. The patient expresses understanding and feels motivated to maintain these lifestyle changes. This positive response sets a solid foundation for ongoing management and opens the door for future discussions about potential titration of medications to further optimize cardiac function.

Section 4

During a routine follow-up appointment four weeks later, the patient presents with a slight increase in fatigue and a mild return of peripheral edema in the ankles. The patient admits to feeling more tired than usual when performing daily activities, although they have not experienced any significant increase in shortness of breath. The healthcare team decides to perform a thorough assessment to determine the cause of these new symptoms.

Vital signs reveal a blood pressure of 138/85 mmHg, which is slightly higher than the previous reading but still within an acceptable range. The heart rate remains steady at 75 beats per minute, and the respiratory rate is unchanged at 18 breaths per minute with no signs of respiratory distress. The nurse notes a weight gain of 1.5 pounds since the last visit, raising the possibility of increased fluid retention.

A repeat BNP test is conducted, showing a slight increase to 160 pg/mL. While still within a manageable range, this suggests the need for a careful review of the patient’s current regimen and lifestyle adherence. The healthcare team discusses these findings with the patient, reinforcing the importance of strict sodium restriction and adherence to medication. They also educate the patient on recognizing early signs of fluid overload and the importance of regular follow-up visits to adjust the treatment plan as necessary. The patient expresses a commitment to maintaining the prescribed lifestyle changes and is scheduled for another follow-up in two weeks to closely monitor their status.

Section 5

Two weeks later, the patient returns for their follow-up appointment. During the initial assessment, the nurse observes that the patient appears slightly more fatigued than during the previous visit. The patient reports that while they have been diligent with their sodium restriction and medication adherence, they occasionally find it challenging to resist salty snacks. Despite these efforts, the patient notes a persistent feeling of tiredness that affects their ability to perform household chores comfortably.

The nurse conducts a thorough physical assessment, starting with vital signs. Blood pressure is recorded at 140/88 mmHg, marginally elevated compared to the previous visit, indicating a need for closer monitoring. The heart rate is stable at 76 beats per minute, and the respiratory rate remains at 18 breaths per minute, with no apparent respiratory distress. Upon examining the patient’s extremities, the nurse notices mild pitting edema in both ankles, slightly more pronounced than before. This finding, combined with a weight gain of another pound, suggests ongoing fluid retention despite the patient's efforts to manage their condition.

In light of these observations, the healthcare team decides to adjust the patient’s diuretic dosage to enhance fluid management. The nurse reinforces the importance of daily weight monitoring and educates the patient on the benefits of engaging in moderate exercise to improve circulation and energy levels. They also review dietary habits, emphasizing the need to find healthier snack alternatives. The patient expresses understanding and willingness to make these adjustments, and a follow-up appointment is scheduled in another two weeks to evaluate the response to these interventions and ensure continued stability.